Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07248144 bioavailability study in healthy volunteers
NCT07117799Phase 1Completed
- Sponsor
- Pfizer
- Start
- Feb 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of prifetrastat (3 arms), sponsored by Pfizer. Primary endpoints: Area Under the Curve From Time Zero to Extrapolated Infinite Time at 168 hours and Maximum Observed Plasma Concentration at 168 hours. Started Feb 2025; status: completed.
02
Drugs
prifetrastat
Beyond the preview
Go deeper on NCT07117799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07117799.